Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.580
+0.060 (1.70%)
Mar 14, 2025, 11:33 AM EDT - Market open

Iovance Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-372.18-444.04-395.89-342.25-259.58
Upgrade
Depreciation & Amortization
43.6133.1321.1413.988.71
Upgrade
Loss (Gain) From Sale of Assets
-5.57----
Upgrade
Asset Writedown & Restructuring Costs
7.36-0.4--
Upgrade
Loss (Gain) From Sale of Investments
-10.26-3.610.476.011.87
Upgrade
Stock-Based Compensation
109.6362.6384.0269.7740.89
Upgrade
Other Operating Activities
-3-3.41---
Upgrade
Change in Accounts Receivable
-69.19-0.15---
Upgrade
Change in Inventory
-39.92-10.12---
Upgrade
Change in Accounts Payable
-7.844.835.886.98-2.96
Upgrade
Change in Other Net Operating Assets
-5.61-1.08-8.7817.585.95
Upgrade
Operating Cash Flow
-352.98-361.82-292.76-227.94-205.13
Upgrade
Capital Expenditures
-11.07-22.29-20.43-37.57-46.79
Upgrade
Cash Acquisitions
-52.57-212.63---
Upgrade
Investment in Securities
-32.7779.68276.8837.71-271.06
Upgrade
Investing Cash Flow
-96.41-155.24256.460.13-317.85
Upgrade
Long-Term Debt Issued
---1-
Upgrade
Net Debt Issued (Repaid)
---1-
Upgrade
Issuance of Common Stock
403.52465.75192.8238.27576.71
Upgrade
Repurchase of Common Stock
-12.86-2.8-2.65--0.28
Upgrade
Financing Cash Flow
390.66462.96190.15239.27576.42
Upgrade
Foreign Exchange Rate Adjustments
-0.54-2.74---
Upgrade
Net Cash Flow
-59.27-56.84153.8511.4653.44
Upgrade
Free Cash Flow
-364.05-384.11-313.18-265.52-251.93
Upgrade
Free Cash Flow Margin
-221.88%-32305.30%---
Upgrade
Free Cash Flow Per Share
-1.26-1.63-1.97-1.73-1.82
Upgrade
Levered Free Cash Flow
-203.22-211.47-173.54-129.35-141.4
Upgrade
Unlevered Free Cash Flow
-203.22-211.47-173.54-129.35-141.4
Upgrade
Change in Net Working Capital
98.34-2.928.97-38.67-19.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.